Peptide News Digest

GLP-1s in Serious Mental Illness, Tirzepatide After Rotator Cuff Repair, Longer-Acting Teriparatide

GLP-1 use tracks with fewer heart events in serious mental illness, tirzepatide with fewer repeat shoulder surgeries, and peptide gels and bone drugs advance.

5 stories · Covering research, clinical-trials

Editor's Note

Friday's GLP-1 papers came from large health-records studies, with the usual limits. A TriNetX study of about 218,000 adults with serious mental illness, type 2 diabetes, and obesity linked GLP-1 use to fewer heart attacks, heart failure cases, and deaths, a group often left out of trials because antipsychotic drugs drive weight gain. A Penn orthopedics study found fewer repeat rotator cuff surgeries in tirzepatide users than in semaglutide users, though the authors stressed that their data measure billing codes, not healed tendons. The non-GLP-1 work was early but practical: Chinese chemists made fatty-acid versions of the bone drug teriparatide that last longer in blood, a Japanese team's self-assembling peptide gel sealed the cut pancreas better than standard mesh in rats, and a small Brazilian crossover study found a peptide mouth film protected tooth enamel against acid.

Research

GLP-1 Use Linked to Fewer Heart Attacks, Heart Failure Cases, and Deaths in 218,000 Adults With Serious Mental Illness, Diabetes, and Obesity

Researchers from St. John's Episcopal Hospital and Washington University in St. Louis reported in the Journal of the American Heart Association on October 16, 2026 a TriNetX records study of 218,043 adults with serious mental illness, type 2 diabetes, and obesity who were taking antipsychotic or antidepressant drugs. Compared with matched nonusers, GLP-1 users had lower risks of heart attack, heart failure, and death at one and three years, with absolute risk differences at three years of 1.0, 1.8, and 6.5 percentage points; semaglutide and tirzepatide showed the same pattern. The authors cautioned that serious mental illness is varied and that diagnoses came from administrative records.

#glp-1 #mental-health #cardiovascular #real-world-evidence
Research

Penn Study Links Tirzepatide to Half the Rate of Repeat Rotator Cuff Surgery Compared With Semaglutide

University of Pennsylvania orthopedic researchers reported in the Orthopaedic Journal of Sports Medicine on October 16, 2026 a TriNetX study of adults aged 40 to 80 who had arthroscopic rotator cuff repair while taking tirzepatide or semaglutide. Over two years, matched tirzepatide users had a lower rate of a repeat repair (2.83% vs 5.67%; relative risk 0.50) and less opioid and physical therapy use, and users of either drug had about 16% fewer complete re-tears than matched patients on neither. The authors said the data reflect billing codes and health care use, not confirmed tendon healing.

#tirzepatide #semaglutide #orthopedics #real-world-evidence
Research

Shandong Chemists Make Fatty-Acid Versions of Teriparatide That Match Its Bone Effects and Last Longer in Serum

Researchers at Shandong University and the Shandong Academy of Pharmaceutical Science reported in the Journal of Medicinal Chemistry on October 16, 2026 that they used a site-specific chemical ligation method to attach fatty acids of different lengths to teriparatide, the bone-building osteoporosis drug that must be injected daily. Of 12 lipidated versions, four matched native teriparatide's bone-building activity in lab and animal tests, and the lead compound, called 62, was markedly more stable in serum. The goal is a longer-acting osteoporosis injection; the work is preclinical.

#teriparatide #osteoporosis #long-acting-peptides #preclinical
Research

Self-Assembling Peptide Gel SPG-178 Seals the Cut Pancreas Better Than Mesh and Fibrin Glue in Rats

University of Osaka surgeons, with co-authors from Japanese medical device maker Menicon, reported in Scientific Reports on October 15, 2026 a rat study of SPG-178, a self-assembling peptide hydrogel, to prevent pancreatic fistula, a leak of pancreatic fluid that often follows pancreas surgery. Three days after the pancreas was cut, fluid amylase, a marker of leakage, averaged 109 IU/L with SPG-178, compared with 283 in untreated rats and 219 with the standard polyglycolic acid mesh and fibrin glue, and the gel group had fewer adhesions and less tissue damage. Human testing has not been reported.

#peptide-hydrogel #surgery #pancreas #preclinical
Clinical Trials

Mouth Film With Cystatins and a Statherin-Derived Peptide Protected Tooth Enamel From Acid in a 10-Person Brazilian Crossover Study

Researchers at the University of São Paulo's Bauru School of Dentistry reported in the European Journal of Oral Sciences on October 16, 2026 a randomized crossover study in 10 participants comparing a mouth rinse and a dissolving oral film that each contained three plant cystatins and a peptide derived from statherin, a saliva protein that binds enamel. Both formulations protected enamel against a short acid challenge better than their placebos; the film outperformed a fluoride film and the rinse matched Elmex, a commercial fluoride rinse. Participants preferred the film, but the study was very small and short.

#dental-health #salivary-peptides #enamel-erosion

Related Guides